Synthetic BiologybioRxivPreprint
A Dynamically Regulated Designed IL-2 for Tumor-localized Signaling
Howell F. Moffett, Brian D. Weitzner, Michelle M. Lissner…·Marc J. Lajoie
This paper designs a dynamically regulated IL-2 variant that enhances tumor-specific immune responses while reducing systemic toxicity.
DOI 10.64898/2026.09.18.752703